GLP-1 Agonists in Non-Alcoholic Fatty Liver Disease
GLP-1 drugs reduce liver fat and inflammation, but struggle to reverse fibrosis.
Kwame Delgado
Editor at Large
Kwame Delgado is a editor at large at glpletter covering emerging glp-1 indications. Based in Montréal, Kwame has written for glpletter since 2015.
1 story · Montréal
GLP-1 drugs reduce liver fat and inflammation, but struggle to reverse fibrosis.